HANAFLU Trademark
Trademark Overview
On Sunday, December 17, 2023, a trademark application was filed for HANAFLU with the United States Patent and Trademark Office. The USPTO has given the HANAFLU trademark a serial number of 98318084. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, October 22, 2025. This trademark is owned by POP Biotechnologies, Inc.. The HANAFLU trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Vaccine research and development; Vaccine research and development services; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines; Research and development of vaccines and medicines; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Medical research in the fields of cancer and infectious diseases; Medical and scientific research in the field of cancer treatment and diagnosis; Research and development in the field of cancer therapeutics, oncology, nanoparticles, and targeted therapies
Vaccine adjuvants; Vaccine preparations; Vaccines; Vaccines against viral infection; Vaccines for human use; Adjuvants for use with vaccines; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Human vaccine preparations; Therapeutic vaccines; Veterinary vaccines; Viral vaccines; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical preparations for treating cancers and infectious diseases
General Information
| Serial Number | 98318084 |
| Word Mark | HANAFLU |
| Filing Date | Sunday, December 17, 2023 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Wednesday, October 22, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 27, 2024 |
Trademark Statements
| Goods and Services | Vaccine research and development; Vaccine research and development services; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines; Research and development of vaccines and medicines; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Medical research in the fields of cancer and infectious diseases; Medical and scientific research in the field of cancer treatment and diagnosis; Research and development in the field of cancer therapeutics, oncology, nanoparticles, and targeted therapies |
| Goods and Services | Vaccine adjuvants; Vaccine preparations; Vaccines; Vaccines against viral infection; Vaccines for human use; Adjuvants for use with vaccines; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Human vaccine preparations; Therapeutic vaccines; Veterinary vaccines; Viral vaccines; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical preparations for treating cancers and infectious diseases |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, December 17, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, December 17, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | POP Biotechnologies, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Buffalo, NY 14228-2710 |
| Party Name | POP Biotechnologies, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Buffalo, NY 14228-2710 |
Trademark Events
| Event Date | Event Description |
| Sunday, December 17, 2023 | NEW APPLICATION ENTERED |
| Sunday, March 24, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, July 16, 2024 | ASSIGNED TO EXAMINER |
| Thursday, July 18, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 7, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 27, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 27, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 22, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, April 21, 2025 | SOU TEAS EXTENSION RECEIVED |
| Monday, April 21, 2025 | SOU EXTENSION 1 FILED |
| Monday, April 21, 2025 | SOU EXTENSION 1 GRANTED |
| Tuesday, April 22, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, October 21, 2025 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, October 21, 2025 | SOU EXTENSION 2 FILED |
| Wednesday, October 22, 2025 | SOU EXTENSION 2 GRANTED |
| Wednesday, October 22, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
